Keith Lamont Cummings

CIK: 0001809204

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (11.1%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)9 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)7 (38.9%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

PLRX

PLIANT THERAPEUTICS, INC.

Officer

Discretionary Trading P&L

Holdings

Transaction History (18 total)

PLRX
PLIANT THERAPEUTICS, INC.
Apr 17, 2026
Award(A)
Stock Option (Right to Buy)
Direct
110.5K shares-
PLRX
PLIANT THERAPEUTICS, INC.
Apr 17, 2026
Award(A)
Stock Option (Right to Buy)
Direct
113.3K shares-
PLRX
PLIANT THERAPEUTICS, INC.
Apr 17, 2026
Disposition(D)
Stock Option (Right to Buy)
Direct
113.3K shares-
PLRX
PLIANT THERAPEUTICS, INC.
Apr 17, 2026
Disposition(D)
Stock Option (Right to Buy)
Direct
76K shares-
PLRX
PLIANT THERAPEUTICS, INC.
Apr 17, 2026
Award(A)
Stock Option (Right to Buy)
Direct
76K shares-
PLRX
PLIANT THERAPEUTICS, INC.
Apr 17, 2026
Disposition(D)
Stock Option (Right to Buy)
Direct
18.2K shares-
PLRX
PLIANT THERAPEUTICS, INC.
Apr 17, 2026
Award(A)
Stock Option (Right to Buy)
Direct
18.2K shares-
PLRX
PLIANT THERAPEUTICS, INC.
Apr 17, 2026
Disposition(D)
Stock Option (Right to Buy)
Direct
74.3K shares-
PLRX
PLIANT THERAPEUTICS, INC.
Apr 17, 2026
Award(A)
Stock Option (Right to Buy)
Direct
74.3K shares-
PLRX
PLIANT THERAPEUTICS, INC.
Apr 17, 2026
Disposition(D)
Stock Option (Right to Buy)
Direct
124K shares-
PLRX
PLIANT THERAPEUTICS, INC.
Apr 17, 2026
Award(A)
Stock Option (Right to Buy)
Direct
124K shares-
PLRX
PLIANT THERAPEUTICS, INC.
Apr 17, 2026
Disposition(D)
Stock Option (Right to Buy)
Direct
76.2K shares-
PLRX
PLIANT THERAPEUTICS, INC.
Apr 17, 2026
Award(A)
Stock Option (Right to Buy)
Direct
76.2K shares-
PLRX
PLIANT THERAPEUTICS, INC.
Apr 17, 2026
Disposition(D)
Stock Option (Right to Buy)
Direct
110.5K shares-
PLRX
PLIANT THERAPEUTICS, INC.
Jan 22, 2026
Award(A)
Stock Option (Right to Buy)
Direct
400K shares-
PLRX
PLIANT THERAPEUTICS, INC.
Jan 20, 2026
Sale(S)
Direct
24K shares at avg. $1.28$31K
PLRX
PLIANT THERAPEUTICS, INC.
Jan 23, 2025
Award(A)
Direct
56.7K shares-
PLRX
PLIANT THERAPEUTICS, INC.
Jan 17, 2025
Sale(S)
Direct
20.1K shares at avg. $11.20$226K

		Type	Shares	Price		Ownership
Apr 17, 2026	PLRX PLIANT THERAPEUTICS, INC.	Award(A) Stock Option (Right to Buy)	110,500	-	-	Direct
Apr 17, 2026	PLRX PLIANT THERAPEUTICS, INC.	Award(A) Stock Option (Right to Buy)	113,300	-	-	Direct
Apr 17, 2026	PLRX PLIANT THERAPEUTICS, INC.	Disposition(D) Stock Option (Right to Buy)	113,300	-	-	Direct
Apr 17, 2026	PLRX PLIANT THERAPEUTICS, INC.	Disposition(D) Stock Option (Right to Buy)	76,047	-	-	Direct
Apr 17, 2026	PLRX PLIANT THERAPEUTICS, INC.	Award(A) Stock Option (Right to Buy)	76,047	-	-	Direct
Apr 17, 2026	PLRX PLIANT THERAPEUTICS, INC.	Disposition(D) Stock Option (Right to Buy)	18,198	-	-	Direct
Apr 17, 2026	PLRX PLIANT THERAPEUTICS, INC.	Award(A) Stock Option (Right to Buy)	18,198	-	-	Direct
Apr 17, 2026	PLRX PLIANT THERAPEUTICS, INC.	Disposition(D) Stock Option (Right to Buy)	74,250	-	-	Direct
Apr 17, 2026	PLRX PLIANT THERAPEUTICS, INC.	Award(A) Stock Option (Right to Buy)	74,250	-	-	Direct
Apr 17, 2026	PLRX PLIANT THERAPEUTICS, INC.	Disposition(D) Stock Option (Right to Buy)	124,000	-	-	Direct
Apr 17, 2026	PLRX PLIANT THERAPEUTICS, INC.	Award(A) Stock Option (Right to Buy)	124,000	-	-	Direct
Apr 17, 2026	PLRX PLIANT THERAPEUTICS, INC.	Disposition(D) Stock Option (Right to Buy)	76,200	-	-	Direct
Apr 17, 2026	PLRX PLIANT THERAPEUTICS, INC.	Award(A) Stock Option (Right to Buy)	76,200	-	-	Direct
Apr 17, 2026	PLRX PLIANT THERAPEUTICS, INC.	Disposition(D) Stock Option (Right to Buy)	110,500	-	-	Direct
Jan 22, 2026	PLRX PLIANT THERAPEUTICS, INC.	Award(A) Stock Option (Right to Buy)	400,000	-	-	Direct
Jan 20, 2026	PLRX PLIANT THERAPEUTICS, INC.	Sale(S)	24,002	$1.28	$30,723	Direct
Jan 23, 2025	PLRX PLIANT THERAPEUTICS, INC.	Award(A)	56,650	-	$0	Direct
Jan 17, 2025	PLRX PLIANT THERAPEUTICS, INC.	Sale(S)	20,148	$11.20	$225,680	Direct

1-18 of 18 transactions

About Cummings Keith Lamont

Cummings Keith Lamont (SEC CIK 0001809204) files insider reports with the SEC as Chief Financial Officer of PLIANT THERAPEUTICS, INC. (PLRX).

Signal8 holds 5 ownership filings by Cummings Keith Lamont, all Form 4s, filed between Jan 22, 2025 and Apr 17, 2026. Those filings report 18 transactions, from Jan 17, 2025 to Apr 17, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Cummings Keith Lamont's filings is in SOUTH SAN FRANCISCO, CA.

Recent filings by Cummings Keith Lamont

Apr 17, 2026: Grants or awards of PLRX derivative securities (2 lines, Form 4, code A).
Apr 17, 2026: Disposition to issuer transactions of PLRX derivative securities (2 lines, Form 4, code D).
Apr 17, 2026: Grant or award of PLRX derivative securities (Form 4, code A).
Apr 17, 2026: Disposition to issuer transaction of PLRX derivative securities (Form 4, code D).
Apr 17, 2026: Grant or award of PLRX derivative securities (Form 4, code A).

Other insiders filing for PLIANT THERAPEUTICS, INC. (PLRX)

Raben David, Chief Medical Officer
Iannone Robert, Director
Borellini Flavia, Director
CROWELL GAYLE A, Director
MCCOURT Thomas A, Director
Krognes Steve E., Director

How to read Form 4 transaction codes